Can Fite Biofarma (AMEX:CANF) reported quarterly losses of $(1.24) per share which beat the analyst consensus estimate of $(1.43) by 13.29 percent. This is a 71.1 percent increase over losses of $(4.29) per share from the same period last year. The company reported $202.000 thousand in sales this quarter. This is the same as the same period last year.